A double-blind clinical safety study of noni fruit juice

Tahitian Noni International, Research and Development, American Fork, Utah, USA.
Pacific health dialog: a publication of the Pacific Basin Officers Training Program and the Fiji School of Medicine 11/2009; 15(2):21-32.
Source: PubMed


A safety study of TAHITIAN NONI Juice from Tahiti was conducted with ninety-six healthy volunteers. For 28 days, participants consumed one of four daily quantities of noni juice: 0 mL (placebo), 30 mL, 300 mL, or 750 mL. All daily dose formulations were standardized to 750 mL by making up any volume differences with the placebo. Hematology, biochemistry, urinalysis, vital signs, and adverse events measurements were made at 0 (baseline), 2, and 4 weeks, as well as during a two-week follow up (week 6). Electrocardiogram (ECG) measurements were also made for each volunteer during the pre-study screen and at week 6. During the trial, those in the noni groups experienced 20 to 50% fewer total adverse events than those in the placebo group. A marginally significant (P<0.1) reduction in the number of constant adverse events experienced by the volunteers was also found in the 300 mL noni juice group. A similar trend was observed in the other noni juice groups, as well. No other clinically significant differences between any of the groups were noted in the parameters and measurements of this study, nor was there evidence suggesting any adverse dose-related effects. The results of this study indicate that drinking up to 750 mL TAHITIAN NONI Juice per day is safe.

Download full-text


Available from: Claude Jarakae Jensen
  • Source
    • "Therefore, it is possible that a subset of humans may be susceptible to side effects or adverse events associated with short- or long-term TNJ use. Yet, based on its prevalent use in humans with relatively few reports of toxicity [5], the absence of adverse effects in other clinical and preclinical studies [4, 26, 29, 30, 67], and the lack of toxicity with long-term TNJ administration in MMTV-neu mice, noni consumption appears to be safe for the majority of the adult human population. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Morinda citrifolia (noni) is reported to have many beneficial properties, including on immune, inflammatory, quality of life, and cancer endpoints, but little is known about its ability to prevent or treat breast cancer. To test its anticancer potential, the effects of Tahitian Noni Juice (TNJ) on mammary carcinogenesis were examined in MMTV- neu transgenic mice. Mammary tumor latency, incidence, multiplicity, and metastatic incidence were unaffected by TNJ treatment, which suggests that it would not increase or decrease breast cancer risk in women taking TNJ for its other benefits. However, noni may be useful to enhance treatment responses in women with existing HER2/ neu breast cancer since TNJ resulted in significant reductions in tumor weight and volume and in longer tumor doubling times in mice. Remarkably, its ability to inhibit the growth of this aggressive form of cancer occurred with the mouse equivalent of a recommended dose for humans (
    Full-text · Article · Apr 2012 · Evidence-based Complementary and Alternative Medicine
  • Source
    • "Noni fruit may also be a useful natural remedy for the treatment of anxiety and depression. Noni fruit juice has been demonstrated to be well tolerated, even at high doses (West et al., 2009). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The antidepressant effects of Morinda citrifolia (noni) fruit extracts were investigated in vitro with the Monoamine Oxidase (MAO) A and B bioassays. The ethyl acetate extract of freeze-dried noni fruit powder inhibited MAO-A and B enzymes 78 and 49%, respectively. A phytochemical study of the most active extract led to the isolation of nine compounds. Among these, three principles including two flavonoids, kaempferol and quercetin, as well as one lignan, (+)-3,4,3',4'-tetrahydro-9,7'"-epoxylignan-7",9'-lactone, were found to be potent MAO-A and B inhibitors. These findings indicate that noni fruit is a natural MAO-A and MAO-B inhibitor, involving a synergistic effect from multiple active components.
    Full-text · Article ·
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the current study was to evaluate Morinda citrifolia (noni) seed extract, a food ingredient, for potential toxicity and antioxidant activity. Nitrates, nitrites, phytic acid, oxalic acid, as well as aflatoxins B1, B2, G1 and G2 were not detected in the extract. The extract was also non-cytoxic (LC 50 > 1 mg/mL) in the 24 and 40 h brine shrimp toxicity test. There were no symptoms of toxicity in a subacute (28 day) oral toxicity test in Sprague-Dawley rats. Noni seed extract did not display any genotoxic potential in a primary DNA damage test in E. coli PQ37. The extract did exhibit significant antioxidant activity in the Oxygen Radical Absorbance Capacity (ORAC) and Ferric Reducing Antioxidant Power (FRAP) tests.
    Full-text · Article · Jan 2011
Show more